| Typicality: | 0.417 |
| Saliency: | 0.391 |
| of their intent | 7 | other |
| in advance with information | 5 | manner |
| for dietary supplements | 2 | purpose |
| manufacturer → notify → fda | 12 |
| manufacturer → notify → the fda | 12 |
| manufacturer → inform → the fda | 7 |
| manufacturer → be required to notify → the fda | 3 |
| negative | neutral | positive |
| 0.217 | 0.728 | 0.054 |
| Raw frequency | 34 |
| Normalized frequency | 0.391 |
| Modifier score | 0.500 |
| Perplexity | 272.746 |